The mutagenic and cytotoxic effects of many endogenous and exogenous alkylating agents are mitigated by the actions of O 6 -alkylguanine-DNA alkyltransferase (AGT). In humans this protein protects the integrity of the genome, but it also contributes to the resistance of tumors to DNA-alkylating chemotherapeutic agents. Here we report properties of the interaction between AGT and short DNA oligonucleotides. We show that although AGT sediments as a monomer in the absence of DNA, it binds cooperatively to both single-stranded and double-stranded deoxyribonucleotides. This strong cooperative interaction is only slightly perturbed by active site mutation of AGT or by alkylation of either AGT or DNA. The stoichiometry of complex formation with 16-mer oligonucleotides, assessed by analytical ultracentrifugation and electrophoretic mobility shift assays, is 4:1 on single-stranded and duplex DNA and is unchanged by several active site mutations or by protein or DNA alkylation. These results have significant implications for the mechanisms by which AGT locates and interacts with repairable alkyl lesions to effect DNA repair.
O6 -Alkylguanine-DNA alkyltransferase is a ubiquitous repair protein that plays a vital role in minimizing the mutagenic effects of alkylating agents (1-4). It catalyzes the stoichiometric transfer of a variety of alkyl substituents from the O 6 -position of guanine to an active site cysteine, preventing incorrect base pairing caused by these adducts. More than 100 alkyltransferases are now known, and the crystal structures are available for three family members: the Ada-C protein from Escherichia coli (5), the human alkyltransferase (hAGT) 1 (6), and the protein from the thermophilic archaeon, Pyrococcus kodakaraensis (7). All of the known alkyltransferases lack the ability to dealkylate themselves, and no dealkylation activity has been found in cell extracts to date. On this basis, it is widely thought that alkyltransferase participates in a single reaction and is then irreversibly inactivated. Given the apparently nonenzymatic nature of the protein, the protection afforded by alkyltransferase is likely to depend on the regulation of its synthesis and degradation and on its ability to efficiently locate repairable lesions throughout the genome.The mechanisms by which AGT interacts with adduct-containing and adduct-free DNAs are poorly understood. Two contrasting mechanisms have been proposed to date. In the first, single AGT proteins bind normal and lesion-containing DNA, and the distribution of AGT between normal and lesion sites depends on a difference in binding affinity. This model is consistent with the observation that a single AGT monomer is necessary and sufficient to dealkylate a single O 6 -alkyl guanine adduct within a DNA duplex (3). It is supported by the observation that single AGT-DNA complexes are detected by gel shift assay when AGT binds short DNA molecules. These complexes have been interpreted as having a 1:1 AGT:DNA stoichiometry, and the binding affinities have been calculated ...